My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    U-104
    U-104

    Price:
    Market Price:

    This product is for research use only, not for human use. We do not sell to patients.
    Number: - + Pieces(InventoryPieces)
    InvivoChem Cat #: V0895
    CAS #: 178606-66-1Purity ≥98%

    Description: U-104 (MST-104; U104; SLC-0111; NSC-213841) is a novel and potent inhibitor of transmembrane carbonic anhydrase (CA) with potential antineoplastic activity. It inhibits CA IX and CA XII with Ki values of 45.1 nM and 4.5 nM respectively. U-104 shows high in vivo antitumor efficacy in Balb/c mice orthotopically implanted with 4T1 cells.

    References: Cancer Res. 2011 May 1;71(9):3364-76; Oncogene. 2013 Oct 31;32(44):5210-9.

    Customer Validation
    Official Supplier of
    • VE
    • OF
    • YALE
    • hhmi
    • 香港大学
    Related Products
    Publications Citing InvivoChem Products
    • Physicochemical and Storage Information
    • Protocol
    • Quality Control Documentation
    • Related Biological Data
    • Customer Review
    Molecular Weight (MW)309.32
    FormulaC13H12FN3O3S
    CAS No.178606-66-1
    Storage-20℃ for 3 years in powder form
    -80℃ for 2 years in solvent
    Solubility (In vitro)DMSO: 62 mg/mL (200.4 mM)
    Water: < 1 mg/mL
    Ethanol: < 1 mg/mL
    Solubility (In vivo)30% PEG400+0.5% Tween80+5% propylene glycol: 30 mg/mL
    SynonymsMST-104, SLC0111; SLC 0111; U-104; NSC 213841; MST104;  MST 104; NSC-213841; NSC213841; SLC-0111; U104; U 104.


    • Molarity Calculator
    • Dilution Calculator
    • The molarity calculator equation

      Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

      • Mass
      • Concentration
      • Volume
      • Molecular Weight *
      • =
      • ×
      • ×
    • The dilution calculator equation

      Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

      This equation is commonly abbreviated as: C1V1 = C2V2

      • Concentration (start)
      • ×
      • Volume (start)
      • =
      • Concentration (final)
      • ×
      • Volume (final)
      • ×
      • =
      • ×
      • C1
      •  
      • V1
      •  
      • C2
      •  
      • V2
    In Vitro

    In vitro activity: U-104 (50  μM) blocks the mesenchymal phenotype in the cancer stem cells population in hypoxia condition of 4T1 cells. U-104 (<50  μM) significantly reduces migration in a dose-dependent manner in metastatic MDA-MB-231 LM2-4Luc+ cells , with cells growing as compact colonies similar to parental MDA-MB-231 cells. U-104 possesses aromatic groups at the second nitrogen ureido group.


    Cell Assay: U-104 (50 μM) blocks the mesenchymal phenotype in the cancer stem cells population in hypoxia condition of 4T1 cells. U-104 (<50 μM) significantly reduces migration in a dose-dependent manner in metastatic MDA-MB-231 LM2-4Luc+ cells , with cells growing as compact colonies similar to parental MDA-MB-231 cells.

    In VivoU-104 (38 mg/kg) inhibits primary tumor growth in the mice implanted orthotopically with MDA-MB-231 LM2-4Luc+ cells. U-104 (19 mg/kg) inhibits metastases formation in the 4T1 experimental metastasis mice model. U-104 (38 mg/kg) significantly delay primary tumor growth and reduces cancer stem cell population in NOD/SCID mice orthotopically implanted with MDA-MB-231 LM2-4Luc+ cells. U-104 (5 mg/mL, oral gavage) shows a significant delay in tumor growth in Balb/c mice orthotopically implanted with 4T1 cells.
    Animal modelBalb/c mice orthotopically implanted with 4T1 cells.
    Formulation & DosageDissolved in 55.6% PEG 400, 11.1% ethanol and 33% water; 5 mg/kg; oral gavage
    ReferencesCancer Res. 2011 May 1;71(9):3364-76; Oncogene. 2013 Oct 31;32(44):5210-9.


    These protocols are for reference only. InvivoChem does not independently validate these methods.

    U-104

    The metastatic 4T1 primary tumor is a valid preclinical model of hypoxia-induced CAIX expression. Cancer Res. 2011 May 1;71(9):3364-76. 
     

    U-104

    Silencing CAIX expression in metastatic 4T1 cells inhibits cell survival and alters pHe in hypoxia. Cancer Res. 2011 May 1;71(9):3364-76.  
     

    U-104

    Growth of primary breast tumors characterized by hypoxia requires the expression of CAIX. Cancer Res. 2011 May 1;71(9):3364-76. 
     

    U-104

    Inhibition of CAIX expression or activity attenuates metastasis of 4T1 mouse mammary tumors. Cancer Res. 2011 May 1;71(9):3364-76. 
     

    U-104

    Targeting CAIX activity with selective small molecule inhibitors of CAIX attenuates the growth of mouse and human breast tumors. Cancer Res. 2011 May 1;71(9):3364-76. 
     

    U-104

    Novel selective small molecule inhibitors of CAIX inhibit metastasis formation by 4T1 mammary tumor cells. Cancer Res. 2011 May 1;71(9):3364-76. 


    评论

      Home Prev Next Last page / pices

      发评论

      ×
      Your information is safe with us. * Required Fields.
      Products are for research use only;  We do not sell to patients
      Tel: 1-708-310-1919
      Fax: 1-708-557-7486
      Subscribe to our E-newsletter
      • Name*
      • *
      • E-mail*
      • *
      • instructions:
      • *
      Copyright 2020 InvivoChem LLC | All Rights Reserved
      prompt
      Do you confirm the receipt?